Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis.

Hayes CL, Dong J, Galipeau HJ, Jury J, McCarville J, Huang X, Wang XY, Naidoo A, Anbazhagan AN, Libertucci J, Sheridan C, Dudeja PK, Bowdish DME, Surette MG, Verdu EF.

Sci Rep. 2018 Sep 21;8(1):14184. doi: 10.1038/s41598-018-32366-6.

2.

Mechanisms by which gut microorganisms influence food sensitivities.

Caminero A, Meisel M, Jabri B, Verdu EF.

Nat Rev Gastroenterol Hepatol. 2018 Sep 13. doi: 10.1038/s41575-018-0064-z. [Epub ahead of print] Review.

PMID:
30214038
3.

Common ground: shared risk factors for type 1 diabetes and celiac disease.

Verdu EF, Danska JS.

Nat Immunol. 2018 Jun 20. doi: 10.1038/s41590-018-0130-2. [Epub ahead of print] Review.

PMID:
29925984
4.

Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.

Libertucci J, Dutta U, Kaur S, Jury J, Rossi L, Fontes ME, Shajib MS, Khan WI, Surette MG, Verdu EF, Armstrong D.

Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G420-G431. doi: 10.1152/ajpgi.00411.2017. Epub 2018 May 31.

PMID:
29848021
5.

Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host.

Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N, Bouziat R, Buscarlet M, Ringus DL, Wang Y, Li Y, Dinh V, Kim SM, McDonald BD, Zurenski MA, Musch MW, Furtado GC, Lira SA, Baier G, Chang EB, Eren AM, Weber CR, Busque L, Godley LA, Verdú EF, Barreiro LB, Jabri B.

Nature. 2018 May;557(7706):580-584. doi: 10.1038/s41586-018-0125-z. Epub 2018 May 16.

PMID:
29769727
6.

Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction.

Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Verschoor CP, Loukov D, Schenck LP, Jury J, Foley KP, Schertzer JD, Larché MJ, Davidson DJ, Verdú EF, Surette MG, Bowdish DME.

Cell Host Microbe. 2018 Apr 11;23(4):570. doi: 10.1016/j.chom.2018.03.006. No abstract available.

7.

High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production.

Miranda PM, De Palma G, Serkis V, Lu J, Louis-Auguste MP, McCarville JL, Verdu EF, Collins SM, Bercik P.

Microbiome. 2018 Mar 22;6(1):57. doi: 10.1186/s40168-018-0433-4.

8.

A commensal Bifidobacterium longum strain improves gluten-related immunopathology in mice through expression of a serine protease inhibitor.

McCarville JL, Dong J, Caminero A, Bermudez-Brito M, Jury J, Murray JA, Duboux S, Steinmann M, Delley M, Tangyu M, Langella P, Mercenier A, Bergonzelli G, Verdu EF.

Appl Environ Microbiol. 2017 Aug 4. pii: AEM.01323-17. doi: 10.1128/AEM.01323-17. [Epub ahead of print]

9.

Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies.

Pinto-Sánchez MI, Causada-Calo N, Bercik P, Ford AC, Murray JA, Armstrong D, Semrad C, Kupfer SS, Alaedini A, Moayyedi P, Leffler DA, Verdú EF, Green P.

Gastroenterology. 2017 Aug;153(2):395-409.e3. doi: 10.1053/j.gastro.2017.04.009. Epub 2017 Apr 18. Review.

10.

Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction.

Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Verschoor CP, Loukov D, Schenck LP, Jury J, Foley KP, Schertzer JD, Larché MJ, Davidson DJ, Verdú EF, Surette MG, Bowdish DME.

Cell Host Microbe. 2017 Apr 12;21(4):455-466.e4. doi: 10.1016/j.chom.2017.03.002. Erratum in: Cell Host Microbe. 2018 Apr 11;23 (4):570.

11.

How infection can incite sensitivity to food.

Verdu EF, Caminero A.

Science. 2017 Apr 7;356(6333):29-30. doi: 10.1126/science.aan1500. No abstract available.

PMID:
28385972
12.

The CD That Pays Dividends: More Than 15 Years of Deamidated Gliadin Peptide Antibodies.

Bai JC, Verdú EF.

Dig Dis Sci. 2017 May;62(5):1110-1112. doi: 10.1007/s10620-017-4528-8. No abstract available.

PMID:
28315033
13.

Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.

De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, Pinto-Sanchez MI, Philip V, McLean PG, Hagelsieb MG, Surette MG, Bergonzelli GE, Verdu EF, Britz-McKibbin P, Neufeld JD, Collins SM, Bercik P.

Sci Transl Med. 2017 Mar 1;9(379). pii: eaaf6397. doi: 10.1126/scitranslmed.aaf6397.

PMID:
28251905
14.

Bifidobacterium infantis NLS Super Strain Reduces the Expression of α-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Active Celiac Disease Patients.

Pinto-Sánchez MI, Smecuol EC, Temprano MP, Sugai E, González A, Moreno ML, Huang X, Bercik P, Cabanne A, Vázquez H, Niveloni S, Mazure R, Mauriño E, Verdú EF, Bai JC.

J Clin Gastroenterol. 2017 Oct;51(9):814-817. doi: 10.1097/MCG.0000000000000687.

PMID:
27636409
15.

Non-coeliac gluten sensitivity: are we closer to separating the wheat from the chaff?

Pinto-Sánchez MI, Verdú EF.

Gut. 2016 Dec;65(12):1921-1922. doi: 10.1136/gutjnl-2016-312471. Epub 2016 Aug 16. No abstract available.

PMID:
27531827
16.

Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease.

Rey M, Yang M, Lee L, Zhang Y, Sheff JG, Sensen CW, Mrazek H, Halada P, Man P, McCarville JL, Verdu EF, Schriemer DC.

Sci Rep. 2016 Aug 2;6:30980. doi: 10.1038/srep30980.

17.

Altered Esophageal Mucosal Structure in Patients with Celiac Disease.

Pinto-Sánchez MI, Nachman FD, Fuxman C, Iantorno G, Hwang HJ, Ditaranto A, Costa F, Longarini G, Wang XY, Huang X, Vázquez H, Moreno ML, Niveloni S, Bercik P, Smecuol E, Mazure R, Bilder C, Mauriño EC, Verdu EF, Bai JC.

Can J Gastroenterol Hepatol. 2016;2016:1980686. doi: 10.1155/2016/1980686. Epub 2016 Feb 29.

18.

Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?

Volta U, Pinto-Sanchez MI, Boschetti E, Caio G, De Giorgio R, Verdu EF.

J Neurogastroenterol Motil. 2016 Oct 30;22(4):547-557. doi: 10.5056/jnm16069. Review.

19.

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.

Caminero A, Galipeau HJ, McCarville JL, Johnston CW, Bernier SP, Russell AK, Jury J, Herran AR, Casqueiro J, Tye-Din JA, Surette MG, Magarvey NA, Schuppan D, Verdu EF.

Gastroenterology. 2016 Oct;151(4):670-83. doi: 10.1053/j.gastro.2016.06.041. Epub 2016 Jun 30.

PMID:
27373514
20.

Novel perspectives on therapeutic modulation of the gut microbiota.

McCarville JL, Caminero A, Verdu EF.

Therap Adv Gastroenterol. 2016 Jul;9(4):580-93. doi: 10.1177/1756283X16637819. Epub 2016 Apr 4. Review.

21.

The complex task of measuring intestinal permeability in basic and clinical science.

Galipeau HJ, Verdu EF.

Neurogastroenterol Motil. 2016 Jul;28(7):957-65. doi: 10.1111/nmo.12871. Review.

PMID:
27339216
22.

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P.

Front Microbiol. 2016 May 6;7:608. doi: 10.3389/fmicb.2016.00608. eCollection 2016.

23.

Mechanisms of innate immune activation by gluten peptide p31-43 in mice.

Araya RE, Gomez Castro MF, Carasi P, McCarville JL, Jury J, Mowat AM, Verdu EF, Chirdo FG.

Am J Physiol Gastrointest Liver Physiol. 2016 Jul 1;311(1):G40-9. doi: 10.1152/ajpgi.00435.2015. Epub 2016 May 5.

24.

Fundamentals of Neurogastroenterology: Basic Science.

Vanner S, Greenwood-Van Meerveld B, Mawe G, Shea-Donohue T, Verdu EF, Wood J, Grundy D.

Gastroenterology. 2016 Feb 18. pii: S0016-5085(16)00184-0. doi: 10.1053/j.gastro.2016.02.018. [Epub ahead of print]

25.

SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis.

Coulombe G, Langlois A, De Palma G, Langlois MJ, McCarville JL, Gagné-Sanfaçon J, Perreault N, Feng GS, Bercik P, Boudreau F, Verdu EF, Rivard N.

J Cell Physiol. 2016 Nov;231(11):2529-40. doi: 10.1002/jcp.25407. Epub 2016 May 8.

26.

Optimization of metabolomics of defined in vitro gut microbial ecosystems.

Wissenbach DK, Oliphant K, Rolle-Kampczyk U, Yen S, Höke H, Baumann S, Haange SB, Verdu EF, Allen-Vercoe E, von Bergen M.

Int J Med Microbiol. 2016 Aug;306(5):280-289. doi: 10.1016/j.ijmm.2016.03.007. Epub 2016 Mar 16. Review.

PMID:
27020116
27.

Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.

Kirkby NS, Chan MV, Zaiss AK, Garcia-Vaz E, Jiao J, Berglund LM, Verdu EF, Ahmetaj-Shala B, Wallace JL, Herschman HR, Gomez MF, Mitchell JA.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):434-9. doi: 10.1073/pnas.1517642113. Epub 2015 Dec 28.

28.

Gluten Introduction to Infant Feeding and Risk of Celiac Disease: Systematic Review and Meta-Analysis.

Pinto-Sánchez MI, Verdu EF, Liu E, Bercik P, Green PH, Murray JA, Guandalini S, Moayyedi P.

J Pediatr. 2016 Jan;168:132-43.e3. doi: 10.1016/j.jpeds.2015.09.032. Epub 2015 Oct 21. Review. Erratum in: J Pediatr. 2016 Feb;169:331.

PMID:
26500108
29.

Should ESPGHAN guidelines for serologic diagnosis of celiac disease be used in adults? A prospective analysis in an adult patient cohort with high pretest probability.

Sugai E, Hwang HJ, Vázquez H, Moreno ML, Costa F, Longarini G, Pinto-Sánchez MI, Niveloni S, Smecuol E, Mazure RM, Verdu EF, Mauriño E, Bai JC.

Am J Gastroenterol. 2015 Oct;110(10):1504-5. doi: 10.1038/ajg.2015.242. No abstract available.

PMID:
26465908
30.

Intestinal microbiota modulates gluten-induced immunopathology in humanized mice.

Galipeau HJ, McCarville JL, Huebener S, Litwin O, Meisel M, Jabri B, Sanz Y, Murray JA, Jordana M, Alaedini A, Chirdo FG, Verdu EF.

Am J Pathol. 2015 Nov;185(11):2969-82. doi: 10.1016/j.ajpath.2015.07.018. Epub 2015 Oct 9.

31.

Pharmacological approaches in celiac disease.

McCarville JL, Caminero A, Verdu EF.

Curr Opin Pharmacol. 2015 Dec;25:7-12. doi: 10.1016/j.coph.2015.09.002. Epub 2015 Sep 27. Review.

PMID:
26414923
32.

Gluten Introduction, Breastfeeding, and Celiac Disease: Back to the Drawing Board.

Lebwohl B, Murray JA, Verdú EF, Crowe SE, Dennis M, Fasano A, Green PH, Guandalini S, Khosla C.

Am J Gastroenterol. 2016 Jan;111(1):12-4. doi: 10.1038/ajg.2015.219. Epub 2015 Aug 11.

33.

Microbiota and host determinants of behavioural phenotype in maternally separated mice.

De Palma G, Blennerhassett P, Lu J, Deng Y, Park AJ, Green W, Denou E, Silva MA, Santacruz A, Sanz Y, Surette MG, Verdu EF, Collins SM, Bercik P.

Nat Commun. 2015 Jul 28;6:7735. doi: 10.1038/ncomms8735.

PMID:
26218677
34.

Prevalence of celiac disease and celiac autoimmunity in the Toba Native Amerindian community of Argentina.

Vázquez H, de la Paz Temprano M, Sugai E, Scacchi SM, Souza C, Cisterna D, Smecuol E, Moreno ML, Longarini G, Mazure R, Bartellini MA, Verdú EF, González A, Mauriño E, Bai J.

Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):431-4. Epub 2015 Jul 24.

35.

Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model.

Natividad JM, Pinto-Sanchez MI, Galipeau HJ, Jury J, Jordana M, Reinisch W, Collins SM, Bercik P, Surette MG, Allen-Vercoe E, Verdu EF.

Inflamm Bowel Dis. 2015 Aug;21(8):1883-93. doi: 10.1097/MIB.0000000000000422.

PMID:
26060932
36.

Novel players in coeliac disease pathogenesis: role of the gut microbiota.

Verdu EF, Galipeau HJ, Jabri B.

Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):497-506. doi: 10.1038/nrgastro.2015.90. Epub 2015 Jun 9. Review.

37.

Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.

Pinto-Sanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D, Moayyedi P, Bercik P.

Am J Gastroenterol. 2015 Jul;110(7):1038-48. doi: 10.1038/ajg.2015.128. Epub 2015 May 12.

PMID:
25964226
38.

Motility alterations in celiac disease and non-celiac gluten sensitivity.

Pinto-Sanchez MI, Bercik P, Verdu EF.

Dig Dis. 2015;33(2):200-7. doi: 10.1159/000371400. Epub 2015 Apr 22. Review.

PMID:
25925923
39.

Extraintestinal manifestations of celiac disease.

Pinto-Sánchez MI, Bercik P, Verdu EF, Bai JC.

Dig Dis. 2015;33(2):147-54. doi: 10.1159/000369541. Epub 2015 Apr 22. Review.

PMID:
25925916
40.

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG.

BMC Microbiol. 2015 Mar 21;15:67. doi: 10.1186/s12866-015-0400-1.

41.

Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries.

Pinto-Sanchez MI, Verdu EF, Gordillo MC, Bai JC, Birch S, Moayyedi P, Bercik P.

Can J Gastroenterol Hepatol. 2015 Mar;29(2):104-10. Review.

42.

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.

Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclée de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JE, Bermúdez-Humarán LG, Smokvina T, Langella P.

Gut Microbes. 2015;6(1):1-9. doi: 10.4161/19490976.2014.990784. Epub 2015 Jan 14.

43.

Gut microbes and adverse food reactions: Focus on gluten related disorders.

Galipeau HJ, Verdu EF.

Gut Microbes. 2014;5(5):594-605. doi: 10.4161/19490976.2014.969635. Review.

44.

BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity.

McCarville JL, Nisemblat Y, Galipeau HJ, Jury J, Tabakman R, Cohen A, Naftali E, Neiman B, Halbfinger E, Murray JA, Anbazhagan AN, Dudeja PK, Varvak A, Leroux JC, Verdu EF.

PLoS One. 2014 Nov 3;9(11):e109972. doi: 10.1371/journal.pone.0109972. eCollection 2014.

45.

Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis.

Flannigan KL, Agbor TA, Blackler RW, Kim JJ, Khan WI, Verdu EF, Ferraz JG, Wallace JL.

Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13559-64. doi: 10.1073/pnas.1413390111. Epub 2014 Sep 3.

46.

Intraluminal administration of poly I:C causes an enteropathy that is exacerbated by administration of oral dietary antigen.

Araya RE, Jury J, Bondar C, Verdu EF, Chirdo FG.

PLoS One. 2014 Jun 10;9(6):e99236. doi: 10.1371/journal.pone.0099236. eCollection 2014.

47.

The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?

De Palma G, Collins SM, Bercik P, Verdu EF.

J Physiol. 2014 Jul 15;592(14):2989-97. doi: 10.1113/jphysiol.2014.273995. Epub 2014 Apr 22. Review.

48.

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG.

Hum Vaccin Immunother. 2014;10(6):1611-21. doi: 10.4161/hv.28549. Epub 2014 Apr 14.

49.

Novel role of the serine protease inhibitor elafin in gluten-related disorders.

Galipeau HJ, Wiepjes M, Motta JP, Schulz JD, Jury J, Natividad JM, Pinto-Sanchez I, Sinclair D, Rousset P, Martin-Rosique R, Bermudez-Humaran L, Leroux JC, Murray JA, Smecuol E, Bai JC, Vergnolle N, Langella P, Verdu EF.

Am J Gastroenterol. 2014 May;109(5):748-56. doi: 10.1038/ajg.2014.48. Epub 2014 Apr 8.

50.

Efficacy of Bifidobacterium breve NCC2950 against DSS-induced colitis is dependent on bacterial preparation and timing of administration.

Hayes CL, Natividad JM, Jury J, Martin R, Langella P, Verdu EF.

Benef Microbes. 2014 Mar;5(1):79-88. doi: 10.3920/BM2013.0039.

PMID:
24533977

Supplemental Content

Loading ...
Support Center